BRANFORD, Conn.–(BUSINESS WIRE)–May 25, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in the Jefferies Healthcare Conference taking place at the Marriott Marquis, New York, NY on June 7-9, 2023. Quantum-Si’s management will present on Thursday, June 8, 2023 at 8:30 AM […]
GUILFORD, Conn.–(BUSINESS WIRE)–May 22, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Jack Kenny, CEO of Meridian Bioscience, Inc., to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230522005246/en/ (Photo: Business Wire) “Jack brings a wealth of experience […]
GUILFORD, Conn.–(BUSINESS WIRE)–May 15, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the election of Scott Mendel, former President and Chief Executive Officer of GenMark Diagnostics, Inc., to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230515005191/en/ Scott Mendel Elected to […]
Q1 2023 revenue $254,000 on orders of $449,000; gross margin 48.8% This was the Company’s first quarter of revenue generated on the sale of PlatinumTM instruments and kits Expect revenue to accelerate in the second half of 2023 based on robust business funnel GUILFORD, Conn.–(BUSINESS WIRE)–May 11, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or […]
Appointment positions company for strategic growth in next-generation protein sequencing GUILFORD, Conn.–(BUSINESS WIRE)–May 2, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Jeff Keyes as its new Chief Financial Officer, effective May 15, 2023. Mr. Keyes brings more than 25 years of experience in senior […]
Quantum-Si Strengthens Commercial, Operations, and Development Teams to Accelerate the Commercial Advancement of the Platinum™ Protein Sequencing Platform GUILFORD, Conn.–(BUSINESS WIRE)–Apr. 24, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointments of Katherine Atkinson as Senior Vice President of Demand Generation and Corporate Brand, Alex Hutcheson […]
GUILFORD, Conn.–(BUSINESS WIRE)–Apr. 20, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will report financial results for the first quarter 2023 on Thursday, May 11, 2023. Company management will host a conference call to discuss financial results and provide a business update on the same […]
GUILFORD, Conn.–(BUSINESS WIRE)–Apr. 14, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced it will be presenting a poster on a new method for detection of arginine post-translational modifications (PTMs) using Platinum™, the world’s first next-generation single-molecule protein sequencing platform, at the American Association for Cancer Research’s (AACR) […]
GUILFORD, Conn.–(BUSINESS WIRE)–Mar. 24, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in B. Riley Securities’ Life Sciences Tools Conference – Proteomics Setting the Blueprint for Innovative Drug Creation, Virtual Conference to be held on Thursday, April 6, 2023. Patrick Schneider, Ph.D., […]
The Company began shipments of Platinum™ instruments and expects to book revenue in Q1 2023 The Company projects an extended cash runway into 2026 GUILFORD, Conn.–(BUSINESS WIRE)– March 6, 2023–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the fourth quarter and fiscal year ended December […]